Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of a Group Intervention Program Based on Acceptance and Mindfulness on the Physical and Emotional Well-being of Overweight and Obese Individuals (Mind&Life)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03718728
Recruitment Status : Active, not recruiting
First Posted : October 24, 2018
Last Update Posted : July 9, 2019
Sponsor:
Collaborators:
Ministerio de Economía y Competitividad, Spain
Basque Health Service
Information provided by (Responsible Party):
Edurne Maiz Aldalur, Basque Country University

Tracking Information
First Submitted Date  ICMJE October 19, 2018
First Posted Date  ICMJE October 24, 2018
Last Update Posted Date July 9, 2019
Actual Study Start Date  ICMJE September 3, 2018
Estimated Primary Completion Date February 14, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: October 26, 2018)
  • Changes in Body Mass Index (BMI) measured by Bio-electrical Impedance Analysis (TANITA) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in Body Mass Index (BMI - kg/m2) will be measured by Bio-electrical Impedance Analysis (TANITA).
  • Changes in eating habits estimated by 24h recall and PREDIMED questionnaire [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in eating habits will be estimated by 24h recall and PREDIMED questionnaire which is a questionnaire to assess the adherence to the Mediterranean diet, 0 being the minimum total score and 14 the maximum total score. Higher values represent a higher adherence to the Mediterranean diet.
  • Changes in the level of physical exercise estimated by the International Physical Activity Questionnaire (IPAQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in the level of physical exercise will be estimated by the International Physical Activity Questionnaire (IPAQ) which is a questionnaire to assess the level of physical activity. This questionnaire obtains the subject's Metabolic Equivalent of Task (MET) of the last week adding up the MET values of the different types of physical activities the subject has done in the last week. Higher values represent a higher level of physical activity.
  • Changes in emotional eating estimated by the Dutch Eating Behaviour Questionnaire (DEBQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in emotional eating will be estimated by the Dutch Eating Behaviour Questionnaire (DEBQ) which is a questionnaire that comprises three scales that measure emotional, external and restrained eating; being 0 the minimum score and 52 the maximum score of the emotional eating scale, 0 the minimum score and 40 the maximum score of the external eating scale and 0 the minimum score and 40 the maximum score of the restrained eating scale. Higher values represent a higher emotional, external or restrained eating.
  • Changes in the quality of life estimated by the Impact of Weight in the Quality of Life-Lite Questionnaire (IWQOL-Lite) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in the quality of life will be estimated by the Impact of Weight in the Quality of Life-Lite Questionnaire (IWQOL-Lite) which is a questionnaire to assess quality of life in obesity. It comprises five subscales that measure weight-related concerns across five domains: Physical Function, Self-Esteem, Sexual Life, Public Distress and Work. The minimum score of the total punctuation is 31 and the maximum punctuation is 155; the minimum score of the Physical Function scale is 11 and the maximum score is 55; the minimum score of the Self-Esteem scale is 7 and the maximum score is 35; the minimum score of the Sexual Life scale is 4 and the maximum score is 20; the minimum score of the Public Distress scale is 5 and the maximum score is 25 and the minimum score of the Work scale is 4 and the maximum is 20. Higher values represent a higher impact of weight in the quality of life of the individual, in the total score and in each of the domains assessed.
  • Changes in weight self-stigma estimated by the Weight Self-Stigma Questionnaire (WSSQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in weight self-stigma will be estimated by the Weight Self-Stigma Questionnaire (WSSQ) which is a questionnaire to assess weight-related self-stigma that comprises two subscales apart from the total punctuation: self-devaluation and fear of enacted stigma. The minimum score of the total punctuation is 0 and the maximum is 72; the minimum score of the Self-Devaluation subscale is 0 and the maximum is 36; the minimum score of the Fear of Enacted-Stigma subscale is 0 and the maximum is 36. Higher values represent a higher weight-related self-stigma, in the total score and in each of the subscales.
Original Primary Outcome Measures  ICMJE
 (submitted: October 23, 2018)
  • Changes in Body Mass Index (BMI) [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by Bio-electrical Impedance Analysis (TANITA)
  • Changes in eating habits [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by 24h recall and PREDIMED questionnaire
  • Changes in the level of physical exercise [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the International Physical Activity Questionnaire (IPAQ)
  • Changes in emotional eating [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Dutch Eating Behaviour Questionnaire (DEBQ)
  • Changes in the quality of life [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Impact of Weight in the Quality of Life-Lite Questionnaire (IWQOL-Lite)
  • Changes in weight self-stigma [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Weight Self-Stigma Questionnaire (WSSQ)
Change History Complete list of historical versions of study NCT03718728 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE
 (submitted: October 26, 2018)
  • Changes in fat percentage measured by Bio-electrical Impedance Analysis (TANITA) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in fat percentage will be measured by Bio-electrical Impedance Analysis (TANITA).
  • Changes in muscle mass percentage measured by Bio-electrical Impedance Analysis (TANITA) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in muscle mass percentage will be measured by Bio-electrical Impedance Analysis (TANITA).
  • Changes in insulin sensitivity measured by homeostasis model assessment (HOMA) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in insulin sensitivity will be measured by homeostasis model assessment (HOMA).
  • Changes in serum lipid profile [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in total, LDL- and HDL-cholesterol will be measured.
  • Changes in glucose profile measured by a spectrophotometry [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in the glucose level will be measured by a spectrophotometry.
  • Changes in waist circumference measured by an inelastic tape (Holtain) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in waist circumference will be measured by an inelastic tape (Holtain).
  • Changes in blood pressure measured by a sphygmomanometer [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in blood pressure will be measured by a sphygmomanometer.
  • Changes in general health estimated by the General Health Questionnaire-28 (GHQ-28) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in general health will be estimated by the General Health Questionnaire-28 (GHQ-28), which is a questionnaire to assess the current general health state. Apart from the total punctuation, it comprises four subscales: Somatic Symptoms, Anxiety/Insomnia, Social Dysfunction and Severe Depression. There are two methods to score the GHQ-28. It can be scored from 0 to 3 for each response with a total possible score on the ranging from 0 to 84. Using this method, a total score of 23/24 is the threshold for the presence of distress. Alternatively, the GHQ-28 can be scored with a binary method where "Not at all", and "No more than usual" score 0, and "Rather more than usual" and "Much more than usual" score 1. Using this method, any score above 4 indicates the presence of distress or 'caseness'.
  • Changes in eating attitudes estimated by the Eating Attitudes Test-12 (EAT-12) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in eating attitudes will be estimated by the Eating Attitudes Test-12 (EAT-12), which is a screening questionnaire to capture undifferentiated eating disorders. Apart from the total punctuation, it comprises three scales: Dieting, Bulimia and food preoccupation and Oral control. The minimum score of the total punctuation is 0 and the maximum score is 36; the minimum score of the Dieting scale is 0 and the maximum score is 12; the minimum score of the Bulimia and food preoccupation is 0 and the maximum score is 12 and the minimum score of the Oral control scale is 0 and the maximum score is 12. Higher values represent further eating problems.
  • Changes in body image's self-perception estimated by the Figure Rating Scale (FRS) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in body image's self-perception will be estimated by the Figure Rating Scale (FRS), which determines body dissatisfaction in women and men. It consists of nine figures of increasing size with accompanying numerical ratings from 1 to 9. Subjects have to choose two figures that represent how they think they look like and their ideal figure. The higher the discrepancy between these figures, the more subjective body dissatisfaction the individual will have.
Original Secondary Outcome Measures  ICMJE
 (submitted: October 23, 2018)
  • Changes in fat percentage [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by Bio-electrical Impedance Analysis (TANITA)
  • Changes in muscle mass percentage [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by Bio-electrical Impedance Analysis (TANITA)
  • Changes in insulin sensitivity [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by homeostasis model assessment (HOMA)
  • Changes in serum lipid profile [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in total, LDL- and HDL-cholesterol
  • Changes in glucose profile [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in the glucose level measured by a spectrophotometry
  • Changes in waist circumference [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by an inelastic tape (Holtain)
  • Changes in blood pressure [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by a sphygmomanometer
  • Changes in general health [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the General Health Questionnaire-28 (GHQ-28)
  • Changes in eating attitudes [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Eating Attitudes Test-12 (EAT-12)
  • Changes in body image's self-perception [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Figure Rating Scale (FRS) which determine body dissatisfaction in women and men
Current Other Pre-specified Outcome Measures
 (submitted: October 26, 2018)
  • Changes in experiential avoidance estimated by the Acceptance and Action Questionnaire-II (AAQ-II) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in experiential avoidance will be estimated by the Acceptance and Action Questionnaire-II (AAQ-II), which is a questionnaire to assess general experiential avoidance and psychological inflexibility, 7 being the minimum total score and 49 being the maximum total score. Higher values represent higher unwillingness to experience unwanted emotions and thoughts.
  • Changes in self-compassion level estimated by the Self-Compassion Scale (SCS) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in self-compassion level will be estimated by the Self-Compassion Scale (SCS), which captures this way of being kind and understanding towards oneself in moments of turmoil. Apart from the total punctuation (overall self-compassion), it comprises six subscales that assess components of self-compassion across three related facets: Self-Kindness/Self-Judgment, Common Humanity/Isolation and Mindfulness/Over-Identification. The minimum total score is 12 and the maximum total score is 60; the minimum score of the Self-Kindness/Self-Judgment subscale is 4 and the maximum score is 20; the minimum score of the Common Humanity/Isolation subscale is 4 and the maximum score is 20; the minimum score of the Mindfulness/Over-Identification scale is 4 and the maximum score is 20. Higher values represent higher overall self-compassion.
  • Changes in mindfulness abilities measured by the Five Facets Mindfulness Questionnaire (FFMQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in mindfulness abilities will be measured by the Five Facets Mindfulness Questionnaire (FFMQ), which is a questionnaire to assess the ability of mindfulness of the individual. Apart from the total punctuation, it comprises five subscales referring to five facets of mindfulness: Observe, Describe, Act with Awareness, Nonjudge of Inner Experience and Non-React to Inner Experience. The minimum score of the total punctuation is 39 and the maximum score is 195; the minimum score of the Observe subscale is 8 and the maximum score is 40; the minimum score of the Describe subscale is 8 and the maximum score is 40; the minimum score of the Act with Awareness subscale is 8 and the maximum score is 40; the minimum score of the Nonjudge of Inner Experience subscale is 8 and the maximum score is 40 and the minimum score of the Non-React to Inner Experience subscale is 7 and the maximum score is 35.
  • Changes in avoidance and inflexibility in relation to difficult weight-related thoughts and feelings estimated by the Acceptance and Action Questionnaire for Weight-Related Problems (AAQ-W) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in avoidance and inflexibility in relation to difficult weight-related thoughts and feelings will be estimated by the Acceptance and Action Questionnaire for Weight-Related Problems (AAQ-W), which is a questionnaire to assess the acceptance of weight-related feelings, defusion from weight related thoughts, and the degree to which thoughts and feelings interfere with valued action, 22 being the minimum score and 154 being the maximum score of the total punctuation. Higher values represent higher experiential avoidance and psychological inflexibility in relation to difficult weight-related thoughts and feelings.
  • Changes in body image flexibility estimated by the Body Image-Acceptance and Action Questionnaire (BI-AAQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in body image flexibility will be estimated by the Body Image-Acceptance and Action Questionnaire (BI-AAQ), which is a questionnaire to assess body image flexibility, 12 being the minimum total score and 84 being the maximum total score. Higher values represent higher body image flexibility.
  • Changes in the fit between participant's actual activities and the valued behavioral pattern measured by Valued Living Questionnaire (VLQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in the fit between participant's actual activities and the valued behavioral pattern will be measured by Valued Living Questionnaire (VLQ), which is a two part instrument to assess valued living. In the first part, subjects rate the importance of 10 domains of living on a 10 point Likert style scale (1 being "not at all important" and 10 being "extremely important") and the second part consists on rating, using a 10 point Likert style scale, how consistently he or she has lived in accord with the valued behavioral pattern within each domain over the past week (1 being "not at all consistent" and 10 being "extremely consistent"). Higher values in the second part represent higher fit between the subject's actual activities and the valued behavioral pattern.
  • Changes in cognitive fusion measured by the Cognitive Fusion Questionnaire (CFQ) [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Changes in cognitive fusion will be measured by the Cognitive Fusion Questionnaire (CFQ), which is a questionnaire to assess the extent to which an individual is psychologically tangled with and dominated by the form or content of his or her thoughts, 7 being the minimum total score and 49 being the maximum total score. Higher values represent higher cognitive fusion.
Original Other Pre-specified Outcome Measures
 (submitted: October 23, 2018)
  • Changes in experiential avoidance [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Acceptance and Action Questionnaire-II (AAQ-II)
  • Changes in self-compassion level [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Self-Compassion Scale (SCS) which capture this way of being kind and understanding towards oneself in moments of turmoil
  • Changes in mindfulness abilities [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by the Five Facets Mindfulness Questionnaire (FFMQ)
  • Changes in avoidance and inflexibility in relation to difficult weight-related thoughts and feelings [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Acceptance and Action Questionnaire for Weight-Related Problems (AAQ-W)
  • Changes in body image flexibility [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Estimated by the Body Image-Acceptance and Action Questionnaire (BI-AAQ)
  • Changes in the fit between participant's actual activities and the valued behavioral pattern [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by Valued Living Questionnaire (VLQ)
  • Changes in cognitive fusion [Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up] [ Time Frame: Pretreatment-Posttreatment (5 months)-7 months follow-up ]
    Measured by the Cognitive Fusion Questionnaire (CFQ)
 
Descriptive Information
Brief Title  ICMJE Effect of a Group Intervention Program Based on Acceptance and Mindfulness on the Physical and Emotional Well-being of Overweight and Obese Individuals
Official Title  ICMJE The Effect of a Group Intervention Program Based on Acceptance and Mindfulness on the Physical and Emotional Well-being of Overweight and Obese Individuals; Mind&Life Project
Brief Summary

The objective of the present study is to evaluate the effect of a 20-week group intervention program based on acceptance and mindfulness in emotional eating, weight loss, physiological parameters and the level of physical exercise, as well as in the quality-of-life and weight self-stigma of overweight and obese people on the short- and medium-term.

Design, participants, and method: A randomized clinical trial comprising a total of 110 overweight or obese (BMI ≥ 25) participants that are receiving medical treatment at Primary Care Centers, 20-65 years, will be included and randomly assigned to standard program (N=55) or standard + intervention program (N=55). The standard program group will receive the treatment as usual (TAU) that comprises 5 sessions (on a monthly basis) that will include a personalized diet and physical exercise recommendations, while the standard + intervention program group will receive the same TAU plus the acceptance and mindfulness-based group intervention program.

At baseline prior to randomization, after the intervention, and seven months after the program has finished anthropometric and body composition data, biochemical data in blood, waist circumference, blood pressure, eating habits, level of physical exercise, general health, emotional eating, quality-of-life, weight self-stigma, experiential avoidance, self-compassion level and mindfulness abilities will be evaluated.

It is hypothesized that the integrated treatment of obesity implementing a group intervention program based on acceptance and mindfulness could help to reduce the emotional eating, enhance weight loss, improve physiological parameters, increase the level of physical exercise, improve the quality of life and reduce the weight self-stigma of overweight and obese individuals.

Detailed Description

The standard program group will receive the TAU that comprises 5 monthly sessions of 30 minutes that will include a personalized diet and physical exercise recommendations.

The standard + intervention program group will receive the same TAU plus the acceptance and mindfulness-based group intervention program. The first ten sessions will be held weekly and the last five, biweekly. The duration of sessions will be 2 hours and will include a mindfulness practice, the session content (i.e. control as the problem, willingness, etc.), followed by a mindful eating practice to train the ability to pay attention to food and eating physical sensations. Finally, the session content will be briefly revised and practices for the week will be established.

The following measurements will be evaluated at baseline prior to randomization, after the intervention, and seven months after the program has finished: anthropometric and body composition data, that is, weight and fat and muscle mass percentage (Bio-electrical Impedance Analysis, TANITA) and height (SECA 227); biochemical data in blood; waist circumference (Holtain inelastic tape); blood pressure; eating habits (24h recall and PREDIMED); level of physical exercise (IPAQ); general health (GHQ-28); emotional eating (DEBQ); quality-of-life (IWQOL-Lite); weight self-stigma (WSSQ); experiential avoidance (AAQ-II); self-compassion level (SCS) and mindfulness abilities (FFMQ).

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Condition  ICMJE Overweight and Obesity
Intervention  ICMJE
  • Behavioral: Mind&Life
    Acceptance and mindfulness-based group intervention program.
  • Behavioral: Standard
    Personalized diet and physical exercise recommendations.
Study Arms  ICMJE
  • Active Comparator: Standard group
    A personalized diet and physical exercise recommendations.
    Intervention: Behavioral: Standard
  • Experimental: Mind&Life (standard + intervention) group
    A personalized diet and physical exercise recommendations plus the acceptance and mindfulness-based group intervention program.
    Interventions:
    • Behavioral: Mind&Life
    • Behavioral: Standard
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Active, not recruiting
Estimated Enrollment  ICMJE
 (submitted: October 23, 2018)
110
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE December 31, 2020
Estimated Primary Completion Date February 14, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Adults with overweight or obesity (estimated by BMI ≥ 25 and classified by the International Obesity Task Force, IOTF);
  • Have asked for enrollment in nutritional treatment for weight loss in primary care units from Donostia-San Sebastian;
  • Willingness to participate in the study.

Exclusion Criteria:

  • Diagnosed with eating disorders; such as, Binge Eating Disorder, Anorexia or Bulimia;
  • Diagnosed with any psychiatric disorder or intellectual disability that doesn't allow to carry out the intervention;
  • Not to know sufficiently the language the intervention is carried out.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 20 Years to 65 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Spain
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03718728
Other Study ID Numbers  ICMJE PSI2017-88583-R
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Edurne Maiz Aldalur, Basque Country University
Study Sponsor  ICMJE Basque Country University
Collaborators  ICMJE
  • Ministerio de Economía y Competitividad, Spain
  • Basque Health Service
Investigators  ICMJE
Principal Investigator: Edurne Maiz Aldalur, PhD Assistant teacher in the Department of Personality, Assessment and Psychological Treatments of the Faculty of Psychology of the Basque Country University (EHU/UPV)
Principal Investigator: Enrique Echeburúa Odriozola, Professor Professor in Clinical Psychology in the Department of Personality, Assessment and Psychological Treatments of the Faculty of Psychology of the Basque Country University (EHU/UPV)
PRS Account Basque Country University
Verification Date July 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP